SCHEMBL3036997

SCHEMBL3036997

Cc1cccc(C)c1O/C=C\C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PTGER4 P35408 7/20 0.40
PTGER3 P43115 7/20 0.40
PTGER2 P43116 7/20 0.40
PTGER1 P34995 6/20 0.39
KMT2A Q03164 2/20 0.39
GAA P10253 1/20 0.39
GPR52 Q9Y2T5 1/20 0.38
FFAR1 O14842 1/20 0.36
HDAC3 O15379 1/20 0.36
TNKS O95271 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3036957 1.00 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL3036850 1.00 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL3045516 0.77 KDM4E (0.41) HPGDKDM4EKMT2AHCAR2LMNA
Maleic Acid SCHEMBL28843794 0.73 KMT2A (0.53) ALDH1A1HPGDKDM4EHSD17B10KMT2A
O-Xylene SCHEMBL6232604 0.72 GAA (0.56) ALDH1A1HPGDKDM4EKMT2AGAA
SCHEMBL16815432 0.72 NFE2L2 (0.55) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL16815431 0.72 NFE2L2 (0.55) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL3045538 0.71 HTT (0.47) ALDH1A1KDM4ESMN1; SMN2GAAFFAR1
SCHEMBL226234 0.71 HTT (0.47) ALDH1A1KDM4ESMN1; SMN2GAAFFAR1
SCHEMBL24043825 0.71 ALDH1A1 (0.50) ALDH1A1HPGDSMN1; SMN2L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470861-B2 Mitochondria-targeted antioxidant prodrugs and methods of use UNIVERSITY OF ROCHESTER (US) 2013-06-25 US disclosed
US-20100168198-A1 Mitochondria-targeted antioxidant prodrugs and methods of use UNIVERSITY OF ROCHESTER 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168198-A1 Mitochondria-targeted antioxidant prodrugs and methods of use TXNRD2, HADHA, PRDX5 ALDH1A1 477/4885HPGD 273/4885KDM4E 3075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.